Sage Therapeutics Board of Directors Initiates Review of Strategic Alternatives and Rejects Biogen’s Unsolicited Acquisition Proposal
Sage Therapeutics, Inc. (Nasdaq: SAGE) ("Sage" or "the Company"), today announced that its Board of Directors has initiated a process to explore strategic alternatives for the Company. The Board ...
pharmaphorum2d
Biogen claims first with FDA nod for biosimilar Actemra
Biogen licensed Tofidence from China’s Bio-Thera Solutions in 2021 and has exclusive rights to market it in all countries excluding China, including Hong Kong and Macau, as well as Taiwan.
Le Lézard7d
FDA and EMA Accept Applications for Higher Dose Regimen of Nusinersen in SMA
Biogen Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted the company's supplemental New Drug Application (sNDA) and the European Medicines Agency (EMA) has validated the ...
marketinference1d
Sage Therapeutics Rejects Biogen's Acquisition Proposal
While the strategic review process is underway, Sage Therapeutics continues to advance its mission of pioneering solutions to deliver life-changing brain health medicines. The company is committed to ...
Chronic Pain Clinical Trial Pipeline Experiences Momentum: Delveinsight Estimates A Diverse Pipeline Comprising 20+ Companies Working In The Domain
Chronic Pain, that persists beyond the usual recovery period or occurs along with a chronic <a target=_blank href= ...
Le Lézard22d
FESARIUSTHERAPEUTICS INC ANNOUNCES FDA 510(K) CLEARANCE FOR DERMISPHERE HYDROGEL DERMAL REGENERATION TEMPLATE
FesariusTherapeutics Inc, an emerging bioregenerative technology company focused on the development, manufacture and commercialization of solutions for the Advanced Wound Care, Reconstructive Surgery ...
EurekAlert!1d
Topical mupirocin lowers lupus inflammation
“In addition to decreasing the inflammation by decreasing lesional staphylococcus aureus, the mupirocin treatment also lowered skin monocyte levels, which are important in driving cutaneous lupus,” ...
Virtualware announces uplisting process to Euronext Growth
Virtualware (EPA: MLVIR), a pioneer in 3D-driven enterprise software, today initiated its uplisting process to the Euronext Growth segment. Speaking from Madrid, Unai Extremo, the company's CEO, ...
wpi.edu1d
New PracticePoint and BETC Director to Keep WPI at Center of Innovation in Healthcare Technology
Liaohai “Leo” Chen, a research scientist who oversaw a $20 million surgical robotics training facility while at the ...
Verywell Health on MSN6d
What's New in Alzheimer's Treatment?
We now have two FDA-approved disease-modifying treatments for Alzheimer's disease, and hundreds of clinical trials are ...
VIRTUALWARE SA: Virtualware announces uplisting process to Euronext Growth
Virtualware (EPA: MLVIR), a pioneer in 3D-driven enterprise software, today initiated its uplisting process to the Euronext Growth segment. Speaking from Madrid, Unai Extremo ...
ncbiotech.org2d
North Carolina booked over $10 billion in life sciences investments in 2024
North Carolina achieved a record-breaking year for life sciences investments in 2024. Twenty-five companies announced ...